SEC Form 4 · accession 0001209191-16-113764
MEDIVATION, INC. · MDVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mohammad Hirmand
Officer — Interim Chief Medical Officer
Period of report
Apr 6, 2016
Accepted (ET)
Apr 8, 2016 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001011835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 6, 2016 | A | 560 | $0.00 | A | 40,239 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $46.45 | Apr 8, 2016 | A | 1,120 | A | — | Apr 8, 2026 | Common Stock | 1,120 | 1,120 | D |
Explanation of responses
- F1Represents the grant of restricted stock units that vest 1/3 on each of May 4, 2017, May 4, 2018 and May 4, 2019.
- F2Includes 337 shares purchased on March 31, 2016 through the Issuer's Employee Stock Purchase Plan.
- F3The shares subject to the option shall become vested according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) shall vest on April 8, 2017, and the remaining shares will vest monthly over the three years thereafter.